Jubilant Life Sciences Limited is an integrated global pharmaceutical and life sciences company engaged in manufacture and supply of APIs, generics, specialty pharmaceuticals and life science ingredients. It also provides services in contract manufacturing and drug discovery. US Food and Drug Administration (USFDA) upgraded Jubilant Hollisterstier's pharmaceutical sterile manufacturing facility in Spokane, Washington (USA) to the status of Voluntary Action Indicated (VAI). This upgradation by the USFDA from Official Action Indicated (OAI) to VAI is indicative of the cGMP status at the facility since receiving the warning letter in 2013.
With 10 world-class manufacturing facilities in India, US and Canada and a team of about 6,200 multicultural people across the globe, the company is committed to deliver value to its customers spread across over 100 countries. The company is well recognized as a ‘partner of choice’ by leading pharmaceuticals and life sciences companies globally.
Commenting on the above development, Shyam S Bhartia, chairman and Hari S Bhartia, co-chairman and managing director, Jubilant Life Sciences, say “Jubilant remains committed to continuous improvements to maintain compliance at all its pharmaceutical manufacturing facilities across the globe. We consider this development as another step towards building a reliable and sustainable pharmaceutical business”.
Subscribe to PharmaTutor News Alerts by Email >>
